URMC /Research / Research@URMC

Featured Blog Post Image

Telomeres Might Predict Lung Cancer Recurrence

Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.

Some Surgeons Still Believe Disproven Old Adage, “Blood Must Be Good”

Despite guidelines to restrict blood transfusions, a wide variation in practice persists across New York State, resulting in complications such as infections and pneumonia, a URMC study concluded.

8/19/2015 | 0 comments

New Discovery May Help Prevent Clotting After Heart Attack

The discovery of a new way that platelets get switched on after a heart attack or stroke may help inform the development of drugs that prevent dangerous clots in patients.

8/18/2015 | 0 comments

Chemotherapy May be Associated with Rare, Early Deaths in Testicular Cancer

A small number of testicular cancer patients—about 11 in 6,909—died of cardiovascular disease in their first year after diagnosis and treatment with chemotherapy, a statistic that’s noteworthy because the cancer itself is usually curable and tends to afflict young men, according to a Wilmot Cancer Institute study.

8/4/2015 | 0 comments

Digital Database Advances Heart Research; Boston Scientific Latest Co. to Access UR Resource

URMC’s Heart Research Follow-up Program is home to an electronic database of millions of ECG recordings that are used by companies and universities to test new ECG technologies and the safety of new drugs. Boston Scientific is the latest company to tap into this resource. 

7/30/2015 | 0 comments

ADHD Medications Pose Risk for Patients With Heart Disorder

ADHD medications, which are known to cause increased heart rate and blood pressure, pose an increased risk to patients with heart rhythm disorders, according to a team of researchers at the University of Rochester Medical Center.

7/29/2015 | 0 comments